Conversion to sirolimus: a successful treatment for posttransplantation Kaposi's sarcoma.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Transplantation

• Publication date

  2004-03-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/01.TP.0000115344.18025.0BPMID 15021843
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sirolimus-based therapy with or without cyclosporine: long-term follow-up in renal transplant patients.

  2005cited by this paper
• Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes.

  2003cited by this paper
• Initiation of angiogenic Kaposi's sarcoma lesions.

  2003cited by this paper
• Rapamycin blocks tumor progression: unlinking immunosuppression from antitumor efficacy1

  2002cited by this paper
• Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor

  2002cited by this paper
• Cyclosporine induces cancer progression by a cell-autonomous mechanism

  1999cited by this paper
• Renal transplantation exposes patients with previous Kaposi's sarcoma to a high risk of recurrence.

  1996cited by this paper
• Cancers in cyclosporine-treated vs azathioprine-treated patients.

  1996cited by this paper
• Mechanism of action of rapamycin: new insights into the regulation of G1-phase progression in eukaryotic cells.

  1995cited by this paper
• Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.

  1994cited by this paper

• Analyzing research trends in the relationship between immunosuppressants and cancer following organ transplantation: a bibliometric study from 2001 to 2023

  2025cites this paper
• A Case of Cutaneous Kaposi Sarcoma in a Patient Post–Heart Transplantation

  2025cites this paper
• Incidence, screening, and management of de novo malignancies in liver transplant patients: A review

  2025cites this paper
• Unraveling the Kaposi Sarcoma-Associated Herpesvirus (KSHV) Lifecycle: An Overview of Latency, Lytic Replication, and KSHV-Associated Diseases

  2025cites this paper
• A Rare Malignancy Postrenal Transplantation – The Dark Side of Success

  2024cites this paper
• Kaposi sarcoma at the base of the tongue in a renal transplant patient

  2023cites this paper
• Long-term management and outcome of lung transplantation in Japan

  2023cites this paper
• Prevention of Oncogenic Gammaherpesvirinae (EBV and HHV8) Associated Disease in Solid Organ Transplant Recipients

  2023cites this paper
• Malignancies in adult kidney transplant candidates and recipients: current status.

  2022cites this paper
• Mammalian target of rapamycin inhibitors for prolonged secondary prevention of nonmelanoma skin cancer in solid organ transplant recipients

  2022cites this paper
• Posttransplant Kaposi sarcoma: Analysis of a series of 13 patients.

  2021cites this paper
• Sarcoma de Kaposi ganglionar postrasplante renal: reporte de dos casos en un centro de trasplante colombiano

  2021cites this paper
• [Successful treatment with paclitaxel of a visceral relapse of post-transplant Kaposi's sarcoma].

  2021cites this paper
• Malignancies in renal transplant recipients: A retrospective single-center descriptive study

  2021cites this paper
• Cancers associated with human gammaherpesviruses

  2021cites this paper
• Rapidly Progressive Pulmonary Kaposi Sarcoma After Bilateral Sequential Lung Transplant: A Case Report.

  2020cites this paper
• Skin and mucosa in patients with solid organ transplant: risks and precautions

  2020cites this paper
• Skin and mucosa in patients with solid organ transplant: risks and precautions

  2020cites this paper
• Preventive Role of mTOR Inhibitor in Post-Kidney Transplant Urothelial Carcinoma.

  2019cites this paper
• Enfermedad de Kaposi

  2019cites this paper
• Kaposi's sarcoma in the immunosuppressed

  2019cites this paper
• Liver Transplantation: Prevention and Treatment of Rejection

  2019cites this paper
• Immunosuppressive drugs in organ transplantation to prevent allograft rejection: Mode of action and side effects

  2019cites this paper
• Posttransplant Malignancy.

  2019cites this paper
• Non-immunological complications following kidney transplantation

  2019cites this paper
• Maladie de Kaposi

  2018cites this paper
• Skin Diseases in the Immunosuppressed

  2018cites this paper
• Cutaneous Malignancies in Solid Organ Transplant Recipients

  2018cites this paper
• Kaposi Sarcoma among non-HIV patients with hematological malignancy: An unusual reality

  2018cites this paper
• mTOR Inhibition Role in Cellular Mechanisms

  2018cites this paper
• Molecular and cellular interplay in virus-induced tumors in solid organ recipients.

  2018cites this paper
• Эффективность поздней конверсии с микофенолатов на эверолимус у реципиентов почечного трансплантата с сопутствующими онкологическими заболеваниями

  2018cites this paper
• ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Intracellular signaling pathways: tyrosine kinase and mTOR inhibitors).

  2018cites this paper
• Skin Cancers in Organ Transplant Recipients

  2017cites this paper
• Risk factors associated with post–kidney transplant malignancies: an article from the Cancer-Kidney International Network

  2017cites this paper
• Assessing the impact of ex vivo perfusion on graft immunogenicity

  2017cites this paper
• The Effect of Conversion from a Calcineurin Inhibitor to Sirolimus on Skin Cancer Reduction in Post-renal Transplantation Patients

  2017cites this paper
• m-TOR Inhibitors in the Current Practice

  2017cites this paper
• Title Conversion to mammalian target of rapamycin inhibitors inkidney transplant recipients with de novo cancers

  2017cites this paper
• The regulatory role of protein phosphorylation in human gammaherpesvirus associated cancers

  2017cites this paper
• Cancer and mTOR Inhibitors in Transplant Recipients.

  2017cites this paper
• Conversion to mammalian target of rapamycin inhibitors in kidney transplant recipients with de novo cancers

  2017cites this paper
• [Infectious and neoplasic complications after kidney transplantation].

  2016cites this paper
• Mammalian target of rapamycin inhibitors: A paradigm shift in current immunosuppression protocols

  2016cites this paper
• Daunting but Worthy Goal: Reducing the De Novo Cancer Incidence After Transplantation

  2016cites this paper
• Role of mTOR inhibitors for the control of viral infection in solid organ transplant recipients

  2016cites this paper
• Malignancy after renal transplantation: a single-centre experience

  2016cites this paper
• SIRT1-mediated downregulation of p27Kip1 is essential for overcoming contact inhibition of Kaposi's sarcoma-associated herpesvirus transformed cells

  2016cites this paper
• Kaposi Sarcoma in the Genital Area in a Kidney Transplant Patient: A Case Report and Literature Review.

  2016cites this paper
• Adapting the Stress Response: Viral Subversion of the mTOR Signaling Pathway

  2016cites this paper
• Role of HHV‐8 and mTOR pathway in post‐transplant Kaposi sarcoma staging

  2016cites this paper
• Management and prevention of post-transplant malignancies in kidney transplant recipients

  2015cites this paper
• Skin cancer in solid organ transplant recipients: are mTOR inhibitors a game changer?

  2015cites this paper
• ABORDAGEM TERAPÊUTICA DO SARCOMA DE KAPOSI

  2015cites this paper
• Incidence, risk factors and outcome of de novo tumors in liver transplant recipients focusing on alcoholic cirrhosis.

  2015cites this paper
• Advances in the therapeutic use of mammalian target of rapamycin (mTOR) inhibitors in dermatology.

  2015cites this paper
• Mammalian target of rapamycin inhibition after solid organ transplantation: can it, and does it, reduce cancer risk?

  2015cites this paper
• A case of esophageal adenocarcinoma on long‐term rapamycin monotherapy

  2015cites this paper
• Minimization vs tailoring: Where do we stand with personalized immunosuppression during renal transplantation in 2015?

  2015cites this paper
• Post-transplantation malignancies: here today, gone tomorrow?

  2015cites this paper
• Cancer Screening of Renal Transplant Patients Undergoing Long-Term Immunosuppressive Therapy.

  2015cites this paper
• ПРИМЕНЕНИЕ ЭВЕРОЛИМУСА ПРИ ЛЕЧЕНИИ САРКОМЫ КАПОШИ ПОСЛЕ ТРАНСПЛАНТАЦИИ ПОЧКИ

  2015cites this paper
• Long‐term Outcomes after Heart Transplantation

  2014cites this paper
• 2 Skin cancer in kidney transplant recipients

  2014cites this paper
• Topical application of rapamycin ointment ameliorates Dermatophagoides farina body extract‐induced atopic dermatitis in NC/Nga mice

  2014cites this paper
• Maintenance Immunosuppressive Therapy

  2014cites this paper
• Recommandations de la SFORL pour la prise en charge des patients immunodéprimés atteints de tumeurs de la tête et du cou de point de départ cutané

  2014cites this paper
• Dramatic recurrence of cancer in a patient who underwent kidney transplant – an analysis of post-transplant cancer recurrence and case report

  2014cites this paper
• French ENT Society (SFORL) guidelines for the management of immunodeficient patients with head and neck cancer of cutaneous origin.

  2014cites this paper
• mTOR inhibitors and renal allograft: Yin and Yang

  2014cites this paper
• Rückgang nicht‐melanozytärer Hauttumoren nach Umstellung der Immunsuppression auf mTOR‐Inhibitoren bei organtransplantierten Patienten

  2014cites this paper
• Dramatic recurrence of cancer in a patient who underwent kidney transplantation--case report.

  2014cites this paper
• General Malignancy after Organ Transplantation

  2014cites this paper
• Long-term care of the heart transplant recipient.

  2014cites this paper
• Manipulation of endothelial cells by KSHV: implications for angiogenesis and aberrant vascular differentiation.

  2014cites this paper
• Non‐melanoma skin cancer is reduced after switch of immunosuppression to mTOR‐inhibitors in organ transplant recipients

  2014cites this paper
• Skin cancer in kidney transplant recipients

  2014cites this paper
• Effect of maintenance immunosuppressive drugs on virus pathobiology: evidence and potential mechanisms

  2013cites this paper
• KSHV vGPCR: A VIRAL ONCOPROTEIN THAT TRIGGERS AUTOPHAGY AND CELLULAR SENESCENCE

  2013cites this paper
• Recommendations on the use of everolimus in lung transplantation.

  2013cites this paper
• Sarcoma de Kaposi: revisión de la literatura e ilustración de un caso

  2013cites this paper
• Molecular mechanisms deployed by virally encoded G protein-coupled receptors in human diseases.

  2013cites this paper
• Malignancies after kidney transplantation: 3 clinical case reports

  2013cites this paper
• Risk of de novo cancers after transplantation: results from a cohort of 7217 kidney transplant recipients, Italy 1997-2009.

  2013cites this paper
• Understanding at the molecular level the consequences of defective ATR signalling in humans

  2013cites this paper
• Sirolimus for the treatment of Kaposi sarcoma after renal transplantation: a series of 10 cases.

  2012cites this paper
• Organ transplantation: historical perspective and current practice.

  2012cites this paper
• Use of Sirolimus in Solid Organ Transplantation

  2012cites this paper
• Malignancy in Kidney Transplant Recipients

  2012cites this paper
• A drug safety evaluation of everolimus in kidney transplantation

  2012cites this paper
• Kaposi's Sarcoma following Chronic Lymphocytic Leukemia: A Rare Entity

  2012cites this paper
• Subversion of autophagy by Kaposi's sarcoma-associated herpesvirus impairs oncogene-induced senescence.

  2012cites this paper
• Immunosuppressive Therapy and Malignancy in Organ Transplant Recipients

  2012cites this paper
• Immunosuppressive drugs in organ transplant recipients--rationale for critical selection.

  2012cites this paper
• Remission eines iatrogenen Kaposi-Sarkoms bei Myasthenia gravis nach Umstellung der Immunsuppression auf den mTOR-Inhibitor Everolimus

  2012cites this paper
• An evaluation of sirolimus in renal transplantation

  2012cites this paper
• Pre- and posttransplant management of solid organ transplant recipients: risk-adjusted follow-up.

  2012cites this paper
• Sarcoma de Kaposi en pacientes trasplantados

  2012cites this paper
• Rapalogs in viral cancers

  2012cites this paper
• Randomized Controlled Trial of Sirolimus for Renal Transplant Recipients at High Risk for Nonmelanoma Skin Cancer

  2012cites this paper